Modulation of the Fce Receptor I Signaling by Tyrosine Kinase Inhibitors: Search for Therapeutic Targets of Inflammatory and Allergy Diseases

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|10|15|1727-1737

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.10, Iss.15, 2004-06, pp. : 1727-1737

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Therapeutic potential of inhaled p38 mitogen-activated protein kinase inhibitors for inflammatory pulmonary diseases

By Chopra Puneet   Kanoje Vijay   Semwal Arvind   Ray Abhijit  

Expert Opinion on Investigational Drugs, Vol. 17, Iss. 10, 2008-10 ,pp. : 1411-1425

Informa Healthcare

Access to resources Recommend Favorite

Rho GTPases as therapeutic targets for the treatment of inflammatory diseases

By Zhao Dezheng   Pothoulakis Charalabos  

Expert Opinion on Therapeutic Targets, Vol. 7, Iss. 5, 2003-10 ,pp. : 583-592

Informa Healthcare

Access to resources Recommend Favorite

Novel Therapeutic Targets for Somatostatin in Inflammatory Chronic Diseases

By  

Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents, Vol. 4, Iss. 1, 2005-02 ,pp. : 91-104

Bentham Science Publishers

Access to resources Recommend Favorite

Fyn Kinase in Brain Diseases and Cancer: The Search for Inhibitors

By  

Current Medicinal Chemistry, Vol. 18, Iss. 19, 2011-06 ,pp. : 2921-2942

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic Potential of Rho-Kinase Inhibitors in Cardiovascular Diseases

By Hirooka Yoshitaka   Shimokawa Hiroaki  

American Journal of Cardiovascular Drugs, Vol. 5, Iss. 1, 2005-01 ,pp. : 31-39

Adis International

Access to resources Recommend Favorite